Outcomes Following Discontinuation of E. coli l-Asparaginase Upon Severe Allergic Reactions in Children With Acute Lymphoblastic Leukemia.

MLA

Yen, Hsiu-Ju, et al. “Outcomes Following Discontinuation of E. Coli l-Asparaginase Upon Severe Allergic Reactions in Children With Acute Lymphoblastic Leukemia.” Pediatric Blood & Cancer, vol. 63, no. 4, Apr. 2016, pp. 665–70. EBSCOhost, https://doi.org/10.1002/pbc.25869.

APA

Yen, H.-J., Chang, W.-H., Liu, H.-C., Yeh, T.-C., Hung, G.-Y., Wu, K.-H., Peng, C.-T., Chang, Y.-H., Chang, T.-K., Hsiao, C.-C., Sheen, J.-M., Chao, Y.-H., Chang, T.-T., Chiou, S.-S., Lin, P.-C., Wang, S.-C., Lin, M.-T., Ho, W.-L., Chen, Y.-C., & Liang, D.-C. (2016). Outcomes Following Discontinuation of E. coli l-Asparaginase Upon Severe Allergic Reactions in Children With Acute Lymphoblastic Leukemia. Pediatric Blood & Cancer, 63(4), 665–670. https://doi.org/10.1002/pbc.25869

Chicago

Yen, Hsiu-Ju, Wan-Hui Chang, Hsi-Che Liu, Ting-Chi Yeh, Giun-Yi Hung, Kang-Hsi Wu, Ching-Tien Peng, et al. 2016. “Outcomes Following Discontinuation of E. Coli l-Asparaginase Upon Severe Allergic Reactions in Children With Acute Lymphoblastic Leukemia.” Pediatric Blood & Cancer 63 (4): 665–70. doi:10.1002/pbc.25869.